Hello runaway,
The OSA side of our business should, IMO, be licenced to doctors specialising in sleep/respiratory or to those companies which market the CPAP units. They have "instant recognition" branding in the marketplace and therefore no real marketing required. Or licence to both. We could also entertain the possibility/feasibility of setting up all telehealth operators with access to the app via a licence deal, to enable them to conduct the sleep tests on their patients directly...at home. However, the number one target is the cpap provider. They will be the one who really wants our app. That will then either be "shelved like the Sarrich engine" or let loose to benefit billions. Any way it goes, we win...!
IMO
- Forums
- ASX - By Stock
- RAP
- Ann: Positive Results from At-Home Sleep Apnoea Study
Ann: Positive Results from At-Home Sleep Apnoea Study, page-60
-
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RAP (ASX) Chart |
Day chart unavailable